Dihexa
Also known as · N-hexanoic-Tyr-Ile-(6) aminohexanoic amide · PNB-0408
Overview
A small oligopeptide derived from the angiotensin IV scaffold, investigated in preclinical models of cognitive impairment for its reported ability to potentiate HGF/c-Met signaling and synaptogenesis. No human trial data are published.
Research profile · for clinicians
Based on research: an angiotensin-IV-derived oligopeptide studied preclinically for cognitive and synaptic effects. Reported to potentiate HGF/c-Met signaling and dendritic spine formation in hippocampal cultures and aged-rodent cognition models.
Mechanism of action
Reported to enhance HGF binding to the c-Met receptor, promoting dendritic spine formation and synaptogenesis in hippocampal cultures and aged rodent cognition models.
Research record
- [01]Reversal of scopolamine-induced cognitive deficits in rats (Harding et al., 2012).
- [02]No published human clinical trials.
Selected references
The angiotensin IV analog Dihexa as a procognitive agent
J. Pharmacol. Exp. Ther., 2012